World TB Day 2021

The clock is ticking

International efforts have succeeded in slowing the COVID-19 epidemic – but responding to COVID-19 has also forced disruption of existing TB control programs around the globe.

It’s time for immediate action to stem the potential flood of TB – including a massive catch-up effort to actively diagnose, trace, treat and prevent the disease.

It’s time to test and treat TB

Tuberculosis is the world’s leading infectious disease killer, claiming 1.4 million lives in 2019. Yet TB is preventable and curable. Only by expanding testing for latent TB infection can we finally end the global TB epidemic.

Customer stories

Eradicating TB in hotspot regions

TB is often relegated as a sickness of impoverished segments of the global population. But TB’s true impact is universal – affecting both rich and poor. Learn how activists and medical experts from TB hotspots are facing and overcoming the challenges of combatting TB.

Learn more
Treating latent TB in rural China

Every tenth tuberculosis infection worldwide occurs in China, making it the country with the third most cases globally. Dr. Gao Lei and his team are fighting to end TB at the source – examining 50,000 people each year in order to conquer the disease on the “front lines” of rural China.

Learn more
Battling tuberculosis in the time of COVID-19

Dr. Alistair Story is putting TB back on the public healthcare radar by bringing testing to susceptible communities – knowing that a disruption in TB services caused by COVID-19 could have dire consequences.

He’s shown that the COVID-19 outbreak can provide an opportunity to identify TB cases that would have otherwise gone undiagnosed.

Read his story
Single visit TB testing to reduce COVID-19 exposure

QuantiFERON-TB Gold Plus offers accurate TB screening with only a single patient visit. Choosing QFT-Plus can reduce potential exposure to COVID-19, while delivering rapid and trustworthy test results.

LEARN MORE
Testing millions to stop tuberculosis migration

In the Gulf region, labor migration is the main source of new TB cases. Currently, those who travel to the region for work are tested for active TB with routine X-ray examinations. However, this practice does not identify asymptomatic individuals infected with latent TB, who may develop the disease and risk infecting others. Learn how Dr. Eskild Petersen, a world-renowned TB expert, is spearheading the fight to end TB in the gulf.

Read his story

Eradicating TB in hotspot regions
Treating latent TB in rural China
Battling tuberculosis in the time of COVID-19
Single visit TB testing to reduce COVID-19 exposure
Testing millions to stop tuberculosis migration

Expert webinars

Watch the expert roundtable discussion
Watch Dr. Manissero, Dr. Oladele, Dr. Tiberi, Prof. Gori, Prof. Drobniewski and Prof. Keshavjee in a lively discussion on TB control and prevention in the time of COVID-19.
WATCH NOW
Live webinar with Dr. Alawode Oladele
Join Dr. Alawode Oladele as he discusses discuss the challenges in testing, treatment, surveillance and investigating TB during the time of the COVID-19 pandemic.
REGISTER NOW

Automated testing

A new automated testing solution to streamline care

QIAGEN and DIASORIN are proud to offer LIAISON QuantiFERON-TB Gold Plus, the first and only FDA-approved, fully automated assay to aid in the diagnosis of TB infection.

LEARN MORE

Knowledge quiz

Improve TB screening with QuantiFERON-TB Gold Plus

The single visit, accurate and cost-effective testing solution.

LEARN MORE

Contact us

QuantiFERON-TB Gold Plus Blood Collection Tubes by QIAGEN, LIAISON Analyzer by DiaSorin.

Product claims may differ from country to country based on regulations and approvals. Contact your country representative for further details.

TB Management